Literature DB >> 26869418

Characterization of Sizes of Aggregates of Insulin Analogs and the Conformations of the Constituent Protein Molecules: A Concomitant Dynamic Light Scattering and Raman Spectroscopy Study.

Chen Zhou1, Wei Qi2, E Neil Lewis2, John F Carpenter3.   

Abstract

To generate aggregates, 3 insulin analogs, lispro, aspart, and glulisine, were incubated without phenolic preservatives for 30 days at 37 °C. As a function of incubation time, aggregation was quantified with size exclusion chromatography, and the sizes of aggregates and the conformations of the constituent molecules were characterized with concomitant dynamic light scattering and Raman spectroscopy. During incubation, lispro was progressively converted into soluble aggregates with hydrodynamic diameters of circa 15 nm, and 95% of the native protein had aggregated at day 30. Raman spectroscopy documented that aggregation resulted in conversion of a large fraction of native alpha helix into nonnative beta sheet structure and a distortion of disulfide bonds. In contrast, for aspart and glulisine only 20% of the native proteins aggregated after 30 days, and minimal structural perturbations were detected. In addition, consistent with the relative aggregation rates during isothermal incubation, Raman spectroscopy showed that during heating the onset temperature for secondary structural perturbations of lispro occurred 7 °C-10 °C lower than those for aspart or glulisine. Overall the results of this study demonstrated that-as in the case during formation of amyloid fibrils from insulin-formation of soluble aggregates of lispro resulted in a high level of conversion of alpha helix into beta sheet.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HPLC (high-performance/pressure liquid chromatography); Raman spectroscopy; dynamic light scattering; particle size; protein aggregation; protein structure; stability

Mesh:

Substances:

Year:  2016        PMID: 26869418     DOI: 10.1016/j.xphs.2015.10.023

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Rapid, quantitative determination of aggregation and particle formation for antibody drug conjugate therapeutics with label-free Raman spectroscopy.

Authors:  Chi Zhang; Jeremy S Springall; Xiangyang Wang; Ishan Barman
Journal:  Anal Chim Acta       Date:  2019-07-10       Impact factor: 6.558

2.  An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein.

Authors:  Michael D Glidden; Khadijah Aldabbagh; Nelson B Phillips; Kelley Carr; Yen-Shan Chen; Jonathan Whittaker; Manijeh Phillips; Nalinda P Wickramasinghe; Nischay Rege; Mamuni Swain; Yi Peng; Yanwu Yang; Michael C Lawrence; Vivien C Yee; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Biol Chem       Date:  2017-11-07       Impact factor: 5.157

3.  Stability and Biological Activity of E. coli Derived Soluble and Precipitated Bone Morphogenetic Protein-2.

Authors:  Bastian Quaas; Laura Burmeister; Zhaopeng Li; Alexandra Satalov; Peter Behrens; Andrea Hoffmann; Ursula Rinas
Journal:  Pharm Res       Date:  2019-11-20       Impact factor: 4.200

4.  Analysis of insulin glulisine at the molecular level by X-ray crystallography and biophysical techniques.

Authors:  Richard B Gillis; Hodaya V Solomon; Lata Govada; Neil J Oldham; Vlad Dinu; Shahwar Imran Jiwani; Philemon Gyasi-Antwi; Frank Coffey; Andy Meal; Paul S Morgan; Stephen E Harding; John R Helliwell; Naomi E Chayen; Gary G Adams
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

5.  Prion-derived tetrapeptide stabilizes thermolabile insulin via conformational trapping.

Authors:  Meghomukta Mukherjee; Debajyoti Das; Jit Sarkar; Nilanjan Banerjee; Jagannath Jana; Jyotsna Bhat; Jithender Reddy G; Jagadeesh Bharatam; Samit Chattopadhyay; Subhrangsu Chatterjee; Partha Chakrabarti
Journal:  iScience       Date:  2021-05-21

6.  Quality Assurance of Commercial Insulin Formulations: Novel Assay Using Infrared Spectroscopy.

Authors:  Sven Delbeck; H Michael Heise
Journal:  J Diabetes Sci Technol       Date:  2020-04-13

7.  Phenolic Preservative Removal from Commercial Insulin Formulations Reduces Tissue Inflammation while Maintaining Euglycemia.

Authors:  Adam Mulka; Brianne E Lewis; Li Mao; Roshanak Sharafieh; Shereen Kesserwan; Rong Wu; Donald L Kreutzer; Ulrike Klueh
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-26

8.  Determination of amyloid core regions of insulin analogues fibrils.

Authors:  Alexey K Surin; Sergei Yu Grishin; Oxana V Galzitskaya
Journal:  Prion       Date:  2020-01-01       Impact factor: 3.931

9.  SAXS Reveals the Stabilization Effects of Modified Sugars on Model Proteins.

Authors:  Astra Piccinini; Eva C Lourenço; Osvaldo S Ascenso; Maria Rita Ventura; Heinz Amenitsch; Paolo Moretti; Paolo Mariani; Maria Grazia Ortore; Francesco Spinozzi
Journal:  Life (Basel)       Date:  2022-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.